COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT OU LA PALLIATION D'UN PATIENT ÂGÉ ATTEINT D'UN CANCER OU D'UN PATIENT ATTEINT D'UN CANCER EN PHASE TERMINALE
An object of the present invention is to provide a novel treatment method with fewer side effects for elderly cancer patients and terminal cancer patients. A pharmaceutical composition for treating or putting an elderly or a terminal cancer patient into remission, comprising, as an active ingredient, (2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoylamino]-4-methylpentanoic acid or a pharmacologically acceptable salt thereof.